Biomarin Pharmaceutical Stock Forward View - Accumulation Distribution
| BMRN Stock | USD 61.73 0.62 1.01% |
Biomarin Stock outlook is based on your current time horizon. Although Biomarin Pharmaceutical's naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Biomarin Pharmaceutical's systematic risk associated with finding meaningful patterns of Biomarin Pharmaceutical fundamentals over time.
The RSI of Biomarin Pharmaceutical's stock price is about 60 suggesting that the stock is rather overbought by investors as of today. The main point of the Relative Strength Index (RSI) is to track how fast people are buying or selling Biomarin, making its price go up or down. Momentum 60
Buy Extended
Oversold | Overbought |
Quarterly Earnings Growth 1.243 | EPS Estimate Next Quarter 0.9872 | EPS Estimate Current Year 5.339 | EPS Estimate Next Year 6.734 | Wall Street Target Price 88.1739 |
Using Biomarin Pharmaceutical hype-based prediction, you can estimate the value of Biomarin Pharmaceutical from the perspective of Biomarin Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Biomarin Pharmaceutical using Biomarin Pharmaceutical's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Biomarin using crowd psychology based on the activity and movement of Biomarin Pharmaceutical's stock price.
Biomarin Pharmaceutical Short Interest
An investor who is long Biomarin Pharmaceutical may also wish to track short interest. As short interest increases, investors should be becoming more worried about Biomarin Pharmaceutical and may potentially protect profits, hedge Biomarin Pharmaceutical with its derivative instruments, or be ready for some potential downside.
200 Day MA 56.5631 | Short Percent 0.0528 | Short Ratio 3.87 | Shares Short Prior Month 7.9 M | 50 Day MA 58.2272 |
Biomarin Relative Strength Index
Biomarin Pharmaceutical Hype to Price Pattern
Investor biases related to Biomarin Pharmaceutical's public news can be used to forecast risks associated with an investment in Biomarin. The trend in average sentiment can be used to explain how an investor holding Biomarin can time the market purely based on public headlines and social activities around Biomarin Pharmaceutical. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Biomarin Pharmaceutical's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Biomarin Pharmaceutical.
Biomarin Pharmaceutical Implied Volatility | 0.54 |
Biomarin Pharmaceutical's implied volatility exposes the market's sentiment of Biomarin Pharmaceutical stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biomarin Pharmaceutical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biomarin Pharmaceutical stock will not fluctuate a lot when Biomarin Pharmaceutical's options are near their expiration.
Biomarin Pharmaceutical after-hype prediction price | USD 62.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Biomarin Pharmaceutical to cross-verify your projections. Prediction based on Rule 16 of the current Biomarin contract
Based on the Rule 16, the options market is currently suggesting that Biomarin Pharmaceutical will have an average daily up or down price movement of about 0.0338% per day over the life of the 2026-05-15 option contract. With Biomarin Pharmaceutical trading at USD 61.73, that is roughly USD 0.0208 . If you think that the market is fully incorporating Biomarin Pharmaceutical's daily price movement you should consider acquiring Biomarin Pharmaceutical options at the current volatility level of 0.54%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Biomarin Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Biomarin Pharmaceutical's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Biomarin Pharmaceutical's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Biomarin Pharmaceutical stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Biomarin Pharmaceutical's open interest, investors have to compare it to Biomarin Pharmaceutical's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Biomarin Pharmaceutical is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Biomarin. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Biomarin Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Biomarin price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biomarin using various technical indicators. When you analyze Biomarin charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 54301.69 | 90323.4 |
| Check Biomarin Pharmaceutical Volatility | Backtest Biomarin Pharmaceutical | Information Ratio |
Biomarin Pharmaceutical Trading Date Momentum
| On February 27 2026 Biomarin Pharmaceutical was traded for 61.73 at the closing time. The top price for the day was 63.22 and the lowest listed price was 60.59 . The trading volume for the day was 2.2 M. The trading history from February 27, 2026 did not affect price variability. The overall trading delta against the current closing price is 1.36% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Biomarin Pharmaceutical to competition |
Other Forecasting Options for Biomarin Pharmaceutical
For every potential investor in Biomarin, whether a beginner or expert, Biomarin Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biomarin Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biomarin. Basic forecasting techniques help filter out the noise by identifying Biomarin Pharmaceutical's price trends.Biomarin Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biomarin Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Biomarin Pharmaceutical could also be used in its relative valuation, which is a method of valuing Biomarin Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biomarin Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Biomarin Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biomarin Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Biomarin Pharmaceutical stock market strength indicators, traders can identify Biomarin Pharmaceutical entry and exit signals to maximize returns.
Biomarin Pharmaceutical Risk Indicators
The analysis of Biomarin Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biomarin Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biomarin stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.52 | |||
| Semi Deviation | 1.36 | |||
| Standard Deviation | 2.69 | |||
| Variance | 7.25 | |||
| Downside Variance | 2.54 | |||
| Semi Variance | 1.86 | |||
| Expected Short fall | (1.76) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Biomarin Pharmaceutical
The number of cover stories for Biomarin Pharmaceutical depends on current market conditions and Biomarin Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biomarin Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biomarin Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Biomarin Pharmaceutical Short Properties
Biomarin Pharmaceutical's future price predictability will typically decrease when Biomarin Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biomarin Pharmaceutical often depends not only on the future outlook of the potential Biomarin Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biomarin Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 197.4 M | |
| Cash And Short Term Investments | 1.6 B |
Check out Historical Fundamental Analysis of Biomarin Pharmaceutical to cross-verify your projections. To learn how to invest in Biomarin Stock, please use our How to Invest in Biomarin Pharmaceutical guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Will Biotechnology sector continue expanding? Could Biomarin diversify its offerings? Factors like these will boost the valuation of Biomarin Pharmaceutical. Projected growth potential of Biomarin fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Biomarin Pharmaceutical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 1.243 | Earnings Share 2.69 | Revenue Per Share | Quarterly Revenue Growth 0.17 | Return On Assets |
Understanding Biomarin Pharmaceutical requires distinguishing between market price and book value, where the latter reflects Biomarin's accounting equity. The concept of intrinsic value - what Biomarin Pharmaceutical's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Biomarin Pharmaceutical's price substantially above or below its fundamental value.
It's important to distinguish between Biomarin Pharmaceutical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Biomarin Pharmaceutical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Biomarin Pharmaceutical's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.